[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Developmental Disabilities & Disorders |
Developmental Disabilities |
Clinical Trial: Morphofunctional Imaging and Developmental Dyslexia
This study is not yet open for patient recruitment.
Verified by University Hospital Tours November 2005
|
Purpose
| Condition | Intervention |
|---|---|
| Developmental Dyslexia, Phonological Treatment, Language, fMRI | Procedure: Morphological and functional MRI |
MedlinePlus consumer health information
Study Type: Observational
Study Design: Cross-Sectional, Defined Population, Prospective Study
Eligibility
Inclusion Criteria:
Developmental dyslexia according to Critchley. Normal PIQ Age : 18-35 years Right handed No hearing deficit. -
Exclusion Criteria:
No head injury No ADHD
-
Location and Contact Information
France
CHU, Tours, 37044, France
Caroline Hommet, MD, PhD, Principal Investigator, CHU Tours
More Information
Last Updated: December 8, 2005
Record first received: November 15, 2005
ClinicalTrials.gov Identifier: NCT00254644
Health Authority: France: Afssaps - French Health Products Safety Agency
ClinicalTrials.gov processed this record on 2006-01-10
Resources
- Accommodations for People with Mental Retardation (Job Accommodation Network)
- Adopting Children with Developmental Disabilities (National Adoption Information Clearinghouse, ACYF, ACF, HHS)

Not Signed In -


